Peptides vs SARMs
Quick Answer Peptides and SARMs are structurally unrelated compound classes that work through entirely different biological pathways – peptides are […]
Quick Answer Peptides and SARMs are structurally unrelated compound classes that work through entirely different biological pathways – peptides are […]
Quick Answer “Chinese peptides” is a cultural term for grey market peptides manufactured in China and sold through unregulated channels
Quick Answer Joe Rogan has discussed peptides including BPC-157, TB-500, ipamorelin, CJC-1295, semaglutide, and thymosin alpha-1 across multiple episodes of
Quick Answer Andrew Huberman has discussed at least 18 named peptides across two dedicated episodes of the Huberman Lab podcast,
Quick Answer The TGA has imposed over AUD 10 million in penalties for peptide-related offences since 2018, scheduled BPC-157 as
Quick Answer The MHRA’s Criminal Enforcement Unit has seized over 25 million doses of illegally traded medicines valued at more
Quick Answer Most research peptides became prescription medicines in New Zealand in December 2025 after Medsafe introduced ten group scheduling
Quick Answer Germany has the most complex peptide regulatory landscape in the EU, governed by two separate laws: the Arzneimittelgesetz
Quick Answer In the European Union, peptides intended for human therapeutic use are classified as medicinal products under Directive 2001/83/EC
Quick Answer Canada regulates injectable peptides as prescription drugs under the Food and Drugs Act – any product sold without
PeptideGuider.com
Independent peptide research resource. Evidence-based coverage of regulatory status, clinical data, and compound analysis.
Commitments
PeptideGuider.com is an informational resource only. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. Many compounds discussed are not approved by the FDA, MHRA, or TGA for human use. Always consult a qualified healthcare professional before making any health-related decisions.
© 2026 PeptideGuider.com. All rights reserved.